Thursday, July 26, 2012

Hyperion Therapeutics prices IPO below proposed range

Hyperion Therapeutics Inc. said Thursday it has priced 5 million shares of its common stock at $10 per share in its initial public offering. This is below a proposed range of $11 to $13 per share. The company had initially planned to offer 4.3 million shares to raise $50 million. The South San Francisco-based biopharmaceutical company is expected to start trading on the Nasdaq Global Select Market under the ticker symbol "HPTX" on Thursday, with the offering closing Tuesday of next week.

No comments:

Post a Comment